WallStreetZenWallStreetZen

NYSE: EVH
Evolent Health Inc Stock Forecast, Predictions & Price Target

Analyst price target for EVH

Based on 7 analysts offering 12 month price targets for Evolent Health Inc.
Min Forecast
$31.00+20.95%
Avg Forecast
$39.14+52.72%
Max Forecast
$45.00+75.58%

Should I buy or sell EVH stock?

Based on 7 analysts offering ratings for Evolent Health Inc.
Strong Buy
Strong Buy
5 analysts 71.43%
Buy
2 analysts 28.57%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EVH stock forecasts and price targets.

EVH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-08
lockedlocked$00.00+00.00%2024-08-27
lockedlocked$00.00+00.00%2024-08-19
lockedlocked$00.00+00.00%2024-08-09
lockedlocked$00.00+00.00%2024-07-30
Canaccord Genuity
Bottom 2%
2
Strong BuyMaintains$41.00+59.97%2024-05-10
Citigroup
Top 27%
74
Strong BuyInitiates Coverage On$40.00+56.07%2024-04-22

1 of 1

Forecast return on equity

Is EVH forecast to generate an efficient return?
Company
N/A
Industry
12.81%
Market
50.07%

Forecast return on assets

Is EVH forecast to generate an efficient return on assets?
Company
N/A
Industry
9.69%

EVH earnings per share forecast

What is EVH's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$0.86
Avg 2 year Forecast
$1.06
Avg 3 year Forecast
$0.86

EVH revenue forecast

What is EVH's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$2.6B+9.52%
Avg 2 year Forecast
$2.9B+24.51%
Avg 3 year Forecast
$3.2B+37.13%
EVH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EVH revenue growth forecast

How is EVH forecast to perform vs Health Information Services companies and vs the US market?
Company
11.26%
Industry
10.07%
Market
9.73%
EVH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EVH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EVH vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
EVH$25.63$39.14+52.72%Strong Buy
GDRX$7.01$10.33+47.40%Strong Buy
BTSG$15.01$18.00+19.92%Strong Buy
TXG$20.11$27.62+37.32%Buy
PRVA$17.08$23.75+39.05%Strong Buy

Evolent Health Stock Forecast FAQ

Is Evolent Health Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NYSE: EVH) stock is to Strong Buy EVH stock.

Out of 7 analysts, 5 (71.43%) are recommending EVH as a Strong Buy, 2 (28.57%) are recommending EVH as a Buy, 0 (0%) are recommending EVH as a Hold, 0 (0%) are recommending EVH as a Sell, and 0 (0%) are recommending EVH as a Strong Sell.

If you're new to stock investing, here's how to buy Evolent Health stock.

What is EVH's earnings growth forecast for 2024-2026?

(NYSE: EVH) Evolent Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 11.05%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.7%.

Evolent Health's earnings in 2024 is -$106,199,000.On average, 4 Wall Street analysts forecast EVH's earnings for 2024 to be $99,428,274, with the lowest EVH earnings forecast at $80,240,362, and the highest EVH earnings forecast at $120,941,994. On average, 4 Wall Street analysts forecast EVH's earnings for 2025 to be $122,686,350, with the lowest EVH earnings forecast at $55,819,382, and the highest EVH earnings forecast at $194,204,933.

In 2026, EVH is forecast to generate $100,009,726 in earnings, with the lowest earnings forecast at $100,009,726 and the highest earnings forecast at $100,009,726.

What is EVH's revenue growth forecast for 2024-2026?

(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 11.26% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.07%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.73%.

Evolent Health's revenue in 2024 is $2,353,868,000.On average, 5 Wall Street analysts forecast EVH's revenue for 2024 to be $299,790,549,962, with the lowest EVH revenue forecast at $297,891,760,654, and the highest EVH revenue forecast at $301,900,290,018. On average, 5 Wall Street analysts forecast EVH's revenue for 2025 to be $340,828,029,227, with the lowest EVH revenue forecast at $324,589,705,865, and the highest EVH revenue forecast at $355,610,164,463.

In 2026, EVH is forecast to generate $375,365,108,886 in revenue, with the lowest revenue forecast at $352,487,767,787 and the highest revenue forecast at $393,775,503,947.

What is EVH's forecast return on assets (ROA) for 2024-2027?

(NYSE: EVH) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 9.69%.

What is EVH's Price Target?

According to 7 Wall Street analysts that have issued a 1 year EVH price target, the average EVH price target is $39.14, with the highest EVH stock price forecast at $45.00 and the lowest EVH stock price forecast at $31.00.

On average, Wall Street analysts predict that Evolent Health's share price could reach $39.14 by Oct 8, 2025. The average Evolent Health stock price prediction forecasts a potential upside of 52.72% from the current EVH share price of $25.63.

What is EVH's Earnings Per Share (EPS) forecast for 2024-2026?

(NYSE: EVH) Evolent Health's current Earnings Per Share (EPS) is -$0.95. On average, analysts forecast that EVH's EPS will be $0.86 for 2024, with the lowest EPS forecast at $0.69, and the highest EPS forecast at $1.04. On average, analysts forecast that EVH's EPS will be $1.06 for 2025, with the lowest EPS forecast at $0.48, and the highest EPS forecast at $1.67. In 2026, EVH's EPS is forecast to hit $0.86 (min: $0.86, max: $0.86).

What is EVH's forecast return on equity (ROE) for 2024-2027?

(NYSE: EVH) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.